Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.

Acta neuropsychiatrica - 1 Dec 2014

de Leon Jose

Abstract excerpt

Personalised medicine has finally been featured in psychiatric journals, but psychiatrists have mainly focused on the promise of using disease mechanisms to personalise treatment. Psychiatric disorders such as schizophrenia and depression are not diseases, in the medical sense, and are probably m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Mental Disorders
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Source

Identifiers

PMID: 25455256
DOI: 10.1017/neu.2014.14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25455256-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.PMID 25455256Read ↗

The future (or lack of future) of personalized prescription in psychiatrySemantic proximity Read ↗

Precision psychiatry - a feasible possibility?Semantic proximity Read ↗

Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.Semantic proximity Read ↗

Pharmacoepidemiology research: Drug therapy and drug safety in mental healthSemantic proximity Read ↗

Do no harm: a paradigm shift in the unchecked use of antidepressants.Semantic proximity Read ↗

[Better understanding of schizophrenia].Semantic proximity Read ↗

Is there a personalized medicine for mood disorders?Semantic proximity Read ↗

[Neurobiological substrates of psychiatric diseases--what can be achieved through therapy?].Semantic proximity Read ↗

The Path to New Therapies for Schizophrenia and Bipolar Illness.Semantic proximity Read ↗

Of Strong Swords and Fine Scalpels: Developing Robust Clinical Principles to Cut Through HeterogeneitySemantic proximity Read ↗

Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophreniaSemantic proximity Read ↗

Management of Antipsychotics in Primary Care: Insights from Healthcare Professionals and Policy Makers in the UKSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.